Toyota|$17.91 (¥2,828)+1.25%▲ (in JPY terms)
Sony|$25.10 (¥3,963)+0.15%▲ (in JPY terms)
SoftBank|$30.09 (¥4,751)+1.47%▲ (in JPY terms)
MUFG|$21.81 (¥3,443)+1.95%▲ (in JPY terms)
Keyence|$496.80 (¥78,430)-0.96%▼ (in JPY terms)
Nintendo|$52.00 (¥8,209)-1.23%▼ (in JPY terms)
NTT|$1.08 (¥171)-0.81%▼ (in JPY terms)
Takeda|$40.24 (¥6,352)+0.71%▲ (in JPY terms)
Tokyo Electron|$62.09 (¥9,802)-0.03%▼ (in JPY terms)
Recruit|$119.09 (¥18,800)+0.00%▲ (in JPY terms)
ITOCHU|$14.62 (¥2,308)-0.15%▼ (in JPY terms)
Honda|$11.21 (¥1,769)+0.37%▲ (in JPY terms)
Shin-Etsu|$38.13 (¥6,020)+0.27%▲ (in JPY terms)
Tokio Marine|$3.57 (¥564)+1.59%▲ (in JPY terms)
Fast Retailing|$463.42 (¥73,160)-0.49%▼ (in JPY terms)
Toyota|$17.91 (¥2,828)+1.25%▲ (in JPY terms)
Sony|$25.10 (¥3,963)+0.15%▲ (in JPY terms)
SoftBank|$30.09 (¥4,751)+1.47%▲ (in JPY terms)
MUFG|$21.81 (¥3,443)+1.95%▲ (in JPY terms)
Keyence|$496.80 (¥78,430)-0.96%▼ (in JPY terms)
Nintendo|$52.00 (¥8,209)-1.23%▼ (in JPY terms)
NTT|$1.08 (¥171)-0.81%▼ (in JPY terms)
Takeda|$40.24 (¥6,352)+0.71%▲ (in JPY terms)
Tokyo Electron|$62.09 (¥9,802)-0.03%▼ (in JPY terms)
Recruit|$119.09 (¥18,800)+0.00%▲ (in JPY terms)
ITOCHU|$14.62 (¥2,308)-0.15%▼ (in JPY terms)
Honda|$11.21 (¥1,769)+0.37%▲ (in JPY terms)
Shin-Etsu|$38.13 (¥6,020)+0.27%▲ (in JPY terms)
Tokio Marine|$3.57 (¥564)+1.59%▲ (in JPY terms)
Fast Retailing|$463.42 (¥73,160)-0.49%▼ (in JPY terms)

2026-04-21 Eisai Co.,Ltd. “An update on the Phase III clinical trial "LITESPARK-012," which evaluates combination therapy as a first-line treatment for patients with advanced renal cell carcinoma (RCC).”

2026-04-21 Eisai Co.,Ltd. “An update on the Phase III clinical trial "LITESPARK-012," which evaluates combination therapy as a first-line treatment for patients with advanced renal cell carcinoma (RCC).”

コメントする